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ABSTRACT 
OBJECTIVE: To assess the prevalence of tuberculosis 
(TB) or a positive skin test in healthcare workers (HCWs) provid- 
ing services to human immunodeficiency virus (HIV)-infected 
individuals and to determine prospectively the incidence of new 
infections in this population. 
DESIGN: This prospective cohort study enrolled 1,014 
HCWs working with HIV-infected populations from 10 metropoli- 
tan areas. Purified protein derivative (PPD) tuberculin skin tests 
were placed at baseline and every 6 months afterwards on those 
without a history of TB or a positive PPD. Demographic, occupa- 
tional, and TB exposure data also were collected. 
SEITING: Outpatient clinics, hospitals, private practice 
offices, and drug treatment programs providing HIV-related 
healthcare and research programs. 
PARTICIPANTS: A voluntary sample of staff and volun- 
teers from 16 Community Programs for Clinical Research on AIDS 
units. 
RESULTS: Factors related to prior TB or a positive skin 
test at baseline included being foreign-born, increased length of 
time in health care, living in New York City, or previous bacille 
Calmette-Guerin vaccination. The rate of PPD conversion was 1.8 
per 100 person years of follow-up. No independent relation was 
found between the amount or type of contact with HIV-infected 
populations and the risk of TB infection. 
CONCLUSION: These data provide some reassurance 
that caring for HIV-infected patients is not related to an increased 
rate ofTB infection among HCWs in these settings (Infect Control 
Hosp Epidemiol 1998;19:829-835). 
As tuberculosis (TB) case rates have increased during 
the past 10 years, many concerns have been raised about the 
risk of acquired TB infection among healthcare workers 
(HCWs).1,2 Recent reports of TB outbreaks in healthcare 
and prison settings have fueled this concern, especially with 
the documentation of multidrug-resistant TB occurring 
among exposed HCWs.3-5 Some individuals have questioned 
whether working primarily with those infected with human 
immunodeficiency virus (HIV) increases an individual 
HCW's risk of acquiring TB. Factors supporting this possi- 
bility include the increased potential for exposure to patients 
with active TB, plus the difficulties encountered in diagnos- 
ing TB in an HIV-infected person.4-8 However, an increased 
level of awareness among HCWs in these settings and the 
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implementation of appropriate infection control procedures 
may offset this risk. 
Few prospective studies have been done to assess 
the risk of acquired TB among HCWs in any setting, as 
measured by purified protein derivative (PPD) tuberculin 
skin-test conversions. One study of medical students in 
Chicago found a conversion rate of 5% during their third 
year of medical school.9 Retrospective studies have found 
baseline prevalence rates of positive PPDs among HCWs as 
high as 50%6 and conversion rates after a known exposure 
as high as 76%.10 Prior to implementing expanded infection 
control guidelines for TB in the early 1990s, Grady 
Memorial Hospital in Atlanta had 1-year conversion rates of 
13.2% for nursing personnel and over 6% for HCWs in gen- 
eral.'1 Little has been documented about the risk of TB 
infection to HCWs working with HIV-infected patients, and 
even less is known about the characteristics of the HCWs 
themselves that may influence the prevalence and inci- 
dence of TB infection or disease in this group. 
To understand the risk of TB in HCWs working with 
HIV-infected patients better, we undertook this study to 
assess the prevalence of TB or a positive skin test and to 
determine prospectively the incidence of new infections in 
this population of HCWs. 
METHODS 
The Terry Beirn Community Programs for Clinical 
Research on AIDS is a National Institutes of Health-funded 
network of 17 units (hospitals, clinics, and private physi- 
cians) across the United States that provides care to HIV- 
infected persons, with a special emphasis on injecting 
drug users, people of color, and women. The staff mem- 
bers and volunteers at 16 of these units were recruited to 
participate in this observational study of the baseline 
prevalence of TB or a positive PPD test and the prospec- 
tive collection of tuberculin skin-test conversion data. Each 
unit submitted information about the number of patients 
seen with HIV or TB, and individual HCWs were recruited 
between September 1992 and May 1993. All HCWs com- 
pleted a questionnaire that included basic demographic 
information, job title and description, past and ongoing 
exposure to TB, and history of work in the healthcare 
field. Each person also was requested to complete an HIV 
status questionnaire, which could be completed and sub- 
mitted anonymously. Participants could identify them- 
selves as being HIV-positive, HIV-negative, unaware of 
HIV status, or unwilling to answer the question. 
Information on race and gender was not collected deliber- 
ately to protect confidentiality further. 
Participants who had no history of prior TB or a pos- 
itive skin test received a baseline test upon entering the 
study, using 5 TU of PPD given intradermally using the 
Mantoux technique. These individuals continued to receive 
a PPD skin test every 6 months until the close of thestudy 
(July 1995), as long as their test remained negative. Two- 
step skin testing was recommended but not required at 
baseline for anyone who had not received a PPD in the past 
2 years. In accordance with published guidelines,12 a 10- 
mm or greater induration at 48 to 72 hours was considered 
positive unless the participant was known to be HIV- 
positive or had been in recent close contact with someone 
diagnosed with TB, in which case a 5-mm or greater indura- 
tion was considered positive. Clinical decisions about TB 
prophylaxis were left to the discretion of the participants 
and their physicians. Information about possible TB expo- 
sure in the community, job responsibilities, and percentage 
of current caseload known to be HIV-infected or to have 
active TB also was collected at each visit. 
Chi-square tests and chi-square tests for linear trend 
were used to assess categorical data. Data tabulated as not 
applicable, unknown, or missing were not included in the 
calculation of test statistics or P values. Stepwise logistic 
regression was used to identify factors independently relat- 
ed to TB infection. Inclusion of variables was stopped when 
no other variables would be statistically significant. 
Additional analyses were done using classification and 
regression trees'3 to explore the data for relationships not 
identified by the logistic regression (because no important 
relationships other than those identified in the logistic 
regression were found, only the logistic regression results 
are reported). A Kaplan-Meier approach was used to esti- 
mate cumulative PPD conversion rates, and a Poisson 
regression was used to compare incidence rates among 
subgroups. A two-sided P less than .05 was considered sta- 
tistically significant. No adjustments were made for multi- 
ple comparisons. 
RESULTS 
A total of 1,014 HCWs were enrolled in the study 
from 16 clinical units, and their demographic and back- 
ground data are provided in Table 1. The greater New York 
City (NYC) area was composed of 6 units, including one 
each from northern New Jersey and southern Connecticut. 
The 10 non-NYC units were located in Atlanta; Chicago; 
Denver; Detroit; New Orleans; Portland, Oregon; 
Richmond, Virginia; Washington, DC; and Wilmington, 
Delaware. Each participating clinical unit was composed of 
one or more subsites. There were 57 sites, of which 56 pro- 
vided site characteristic data. The site with the missing data 
had only one HCW in the study. The research interests of 
this consortium are reflected in the high percentage of 
HIV-infected patients seen at these sites, although each 
study participant saw variable proportions of HIV-infected 
patients, depending on job responsibilities and site charac- 
teristics (eg, drug treatment programs). 
Additional data on the study participants include that 
almost half averaged 10 or more hours per week of direct 
hands-on care of patients, including physical examinations, 
nursing care, and treatments. Eighty-one were both foreign- 
born and had a history of bacille Calmette-Guerin (BCG) 
vaccination. The HIV status questionnaire was returned by 
746 (74%) of the participants. Of those responding, 15 (2%) 
self-reported as HIV-positive, 505 (68%) as HIV-negative, 
210 (28%) as unaware of their HV status, and 16 (2%) chose 
not to answer the question yet returned the form. 
At the time of enrollment, 209 (21%) of the HCWs 
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TABLE 1 
RELATION OF DEMOGRAPHIC AND OCCUPATIONAL CHARACTERISTICS IN 1,014" HEALTHCARE WORKERS DEFINED AS POSITIVE AT ENTRY 
Characteristic No. (%) Percentage Positive at Study Entry P 
Age 
<30 190 (18.8) 17.4 <.001t 
30-39 413 (40.9) 22.5 
40-49 275 (27.3) 26.2 
>50 131 (13.0) 35.9 
Area of country 
NYC area 546 (53.8) 31.1 <.001 
Non-NYC area 468 (46.2) 16.7 
Foreign-born (or resided >1 y in endemic area) 
Yes 214 (21.1) 51.4 <.001 
No 800 (78.9) 17.3 
BCG vaccination in past 
Yes 105 (10.4) 75.2 <.001 
No 805 (79.4) 16.3 
Uncertain or missing 104 (10.3) 36.5 
Occupation type 
Physicians 182 (18.0) 34.1 .002 
PAs, NPs, or nurses 264 (26.1) 27.3 
Social workers or counselors 134 (13.2) 21.6 
Clerical 155 (15.3) 17.4 
Other 278 (27.4) 20.5 
Years in heath care 
<5 249 (26.3) 13.7 <.001t 
5-9 204 (21.5) 24.0 
10-14 203 (21.4) 23.2 
>15 292 (30.8) 31.8 
Years worked with HIV-infected patients 
<5 519 (55.1) 21.8 .105t 
5-9 305 (32.4) 25.3 
>10 118 (12.5) 28.0 
Proportion of patients with HIV infection 
0%-24% 203 (20.0) 19.7 .141t 
259-49% 98 (9.7) 27.6 
50%-74% 155 (15.3) 25.2 
75%-100% 438 (43.2) 26.0 
Unknown, not applicable, or missing 120 (11.8) 23.3 
Proportion of patients with active TB 
0%-24% 683 (67.4) 23.3 <.001t 
25%-49% 57 (5.6) 36.8 
50%-74% 25 (2.5) 44.0 
75%-100% 14 (1.4) 42.9 
Unknown, not applicable, or missing 235 (23.2) 21.7 
Performs any cough-inducing procedures?* 
Yes 316 (31.2) 31.7 <.001 
No 698 (68.8) 21.2 
Current occupational setting 
Outpatient 265 (26.2) 17.7 <.001 
Hospital-based 554 (54.7) 28.9 
Private practice 89 (8.8) 13.5 
Drug treatment program 74 (7.3) 29.7 
Other 31 (3.1) 22.6 
Abbreviations: BCG, bacille Calmette-Guerin; HCW, healthcare worker; HIV, human immunodeficiency virus; NP, nurse practitioner; NYC, New York City; PA, physician assistant; TB, tuberculosis. 
* Certain data missing for some HCWs. 
t Chi-square test for trend. 
SBronchoscopies, endoscopies, sputum collection, administration of aerosols. 
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TABLE 2 
MULTrIVARIATE ANALYSIS OF HISTORY OF TUBERCULOSIS OR A 
POSITIVE PURIFIED PROTEIN DERIVATIVE IN 805 HEALTHCARE 
WORKERS WHO DID NOT HAVE A PRIOR BACILLE CALMETTE- 
GUERIN VACCINATION 
Predictor OR CI, P 
New York City area 1.82 (1.21-2.74) .004 
Foreign-born 2.07 (1.23-3.49) .006 
Years as HCW (5-year periods)* 1.37 (1.23-1.52) <.0001 
Abbreviations: CIs, 95% confidence interval; HCW, healthcare worker; OR, odds ratio. 
* For every 5year increment, the odds ratio increases 37% 
had a history ofTB or a history of a positive tuberculin skin 
test. Information about time of PPD positivity, time of entry 
into the healthcare field, and time working with HIV- 
infected patients was provided by 157 of 201 HCWs who 
had a history of a positive tuberculin skin test. Of these, 
25% tested positive before working in health care, 25% after 
entering health care but before working with HIV-infected 
patients, and the remaining 50% after starting to work with 
HIV-positive patients. The 805 HCWs with no history of 
either TB or a positive skin test received a baseline PPD; 39 
had new positive skin tests, and 766 had a negative PPD. 
Thus, of the 1,014 HCWs enrolled, a total of 248 (24%) were 
defined as positive at study entry, with a history of active 
TB, or a newly or previously positive PPD test. 
The percentage of HCWs who were positive at study 
entry in various subgroups is given in Table 1. Several fac- 
tors were significantly related to a higher rate of positivity, 
including BCG vaccination in the past. Factors that did not 
appear to have an impact included the percentage of the 
patient caseload who were known to be HIV-infected, years 
working with HIV-infected patients, and having direct or 
indirect contact with HIV-infected patients (counseling or 
educational sessions, scheduling appointments, etc). 
Multiple logistic regression analyses were per- 
formed to identify factors that were independently related 
to being positive at study enrollment. The variables includ- 
ed were age, working in the NYC area, being foreign born 
or previously residing in a TB endemic area, BCG vaccina- 
tion in the past, occupational type, years in the healthcare 
field, years in the HIV field, proportion of patients cared for 
with HIV, proportion of patients cared for with active TB, 
hours of direct hands-on care, and the performance of 
cough-inducing procedures including bronchoscopies, 
endoscopies, and the administration of aerosols. 
Interactions of other variables with a history of BCG 
vaccination were suggested by both logistic regression and 
classification and regression tree analyses. Thus, the logis- 
tic regression was performed separately for those with and 
without a BCG vaccination. For the subset with a history of 
BCG vaccination, no other variables were found to be sig- 
nificantly related to positivity at study entry. For those with- 
out a known history of BCG vaccination, three factors were 
significantly related to baseline positivity: working in the 
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FIGURE. Kaplan-Meier curve of purified protein derivative conversion rate of 
766 healthcare workers who were negative at baseline and retested every 6 
months. 
TB endemic area, and length of time as an HCW (Table 2). 
Age, providing direct patient care, performing cough- 
inducing procedures, and working with HIV-infected 
patient populations were not found to be independent pre- 
dictors of acquired TB or a positive skin test at baseline. 
Of the 766 HCWs who were followed in the prospec- 
tive portion of the study with skin testing every 6 months, 
376 were from the greater New York City area, and 390 
came from the 10 other units. Twenty-six had a prior histo- 
ry of BCG vaccination, 73 had received two-step testing at 
baseline, and 13 had self-reported as being HIV-infected. 
The average length of follow-up was 19.6 months, with 66% 
receiving at least three follow-up skin tests. A total of 22 
HCWs (3%) converted their PPD or received TB prophy- 
laxis during the course of the study, at a rate of 1.8 per 100 
person years of follow-up. Kaplan-Meier estimates of PPD 
conversion are shown in the Figure. Of the initial cohort, 
441 (58%) attended a final study visit or were counted in the 
conversion group. Of the 325 HCWs who missed the final 
visit, 244 (75.1%) had moved or changed occupation during 
the course of the study. 
There were no reported cases of active TB among 
the participating HCWs at any of the units during the study. 
Only one converter had reported a prior history of BCG 
vaccination, three had received two-step baseline testing, 
and none of the self-identified HIV-positive HCWs convert- 
ed their PPD while participating in this study. Fourteen of 
the 22 skin-test conversions occurred in three units: one 
unit in NYC (5 conversions), Richmond (6 conversions), 
and New Orleans (3 conversions). None of these conver- 
sions were associated with each other through a known 
cluster of conversions after exposure to an index case of 
TB. Of 17 converters with no induration at baseline, 2 had 
follow-up indurations between 10 and 14 mm, 9 had 
between 15 and 20 mm, and 6 had indurations greater than 
20 mm. Two HCWs with baseline indurations between 5 
and 9 mm had follow-up indurations between 10 and 14 mm 
and were assessed by unit staff as being converters. Three 
HCWs with no induration at baseline were counted as con- 
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TABLE 3 
PURIFIED PROTEIN DERIVATIVE CONVERSION RATES BY OCCUPATIONAL RISK FACTORS 
Occupational Risk Factor No. PPD+ Rate* Ci95t P 
Work in NYC 
Yes 376 9 1.6 (0.8-3.1) 
No 390 13 1.8 (1.0-3.1) .80 
Performs any cough-inducing procedures 
Yes 216 9 2.4 (1.1-4.5) 
No 550 13 1.5 (0.8-2.5) .28 
Occupation 
MD, PA, NP, or nurses 430 11 1.7 (0.8-3.0) 
SW, counselor, clerical, or other 336 11 1.8 (0.9-3.3) .88 
Proportion of patients with HIV 
0%9-49% 234 6 1.7 (0.6-3.7) 
50%-100% 440 14 1.8 (1.0-3.0) .99 
Unknown or N/A 92 2 1.6 (0.2-5.8) 
Proportion of patients with active TB 
0%96-24% 524 15 1.7 (1.0-2.8) 
25%-100% 58 4 4.6 (1.2-11.7) .15 
Unknown or N/A 184 3 1.0 (0.2-3.0) 
Current occupational setting 
Outpatient 218 0 0.0 (0.0-1.1) <.0001 
Hospital-based 394 13 1.9 (1.0-3.2) 
Private practice 77 4 3.2 (0.9-8.2) 
Drug treatment program 52 5 9.5 (3.1-22.1) 
Other 24 0 0.0 (0.0-9.7) 
Overall 766 22 1.8 (1.1-2.7) 
Abbreviations: CIs, 95% confidence interval; HIV, human immunodeficiency virus; MD, physician; N/A, not applicable; NP, nurse practitioner; NYC, New York City; PA, physician assistant; PPD+, 
purified protein derivative positive; SW, social worker; TB, tuberculosis. 
* Rate per 100 person years. 
t Based on assumption that events have a Poisson distribution. 
verters due to material exposure to cases of TB and subse- 
quent prophylaxis. These three, per instructions in the pro- 
tocol, did not receive further PPD testing, and thus it is 
unknown if they really were converters. 
There was no apparent relation between caring for 
HIV-infected individuals and the rate of PPD conversion 
among our HCW cohort (Table 3). Those who performed 
cough-inducing procedures had tendencies toward higher 
conversion rates than those who didn't, but without appar- 
ent correlation to the HIV status of the patients. Working in 
settings with a higher proportion of patients with active TB 
appeared to increase the risk of acquiring TB infection, as 
did working in private practice or drug treatment pro- 
grams. Using the variables in Table 3, a multivariate logis- 
tic analysis was performed to identify independent risk fac- 
tors for PPD conversion. The only statistically significant 
finding associated with an increased risk of conversion was 
the occupational setting of a drug treatment program com- 
pared to all other settings (odds ratio, 4.4; 95% confidence 
interval, 1.5-12.3; P=.006). 
DISCUSSION 
As the most important opportunistic infection asso- 
ciated with HIV that can be transmitted to the general pop- 
ulation, TB warrants special concern among providers of 
health care and other services to HIV-infected popula- 
tions. Multiple instances of patient-to-patient and patient- 
to-HCW transmission of TB infection have been docu- 
mented.3-7,14,15 Delays in diagnosing active cases of TB, 
plus antiquated and inadequate ventilation systems in cer- 
tain hospitals and other healthcare facilities, contribute to 
the problem of TB transmission.11,16-18 In several cases of 
known exposure to an index case of TB, as many as 50% to 
76% of HCWs had documented skin-test conversions.1,'0 
The majority of these reported cases of transmission have 
involved patients coinfected with HIV, leading to the pre- 
sumption that working with HIV-infected populations may 
increase the risk to HCWs of acquiring TB infection. With 
HIV infection increasing among populations already 
known to be at risk for TB infection,19 HCWs may 
encounter more patients with undiagnosed TB and may 
have a higher risk of becoming infected themselves. This 
is of special concern to the HIV-infected HCW, where the 
risk of acquisition of infection appears to be higher and 
the likelihood of progression to disease more certain.20 
Our study included a large, diverse sample of 1,014 
persons working in healthcare settings with HIV-infected 
clients. We identified four factors associated with being 
This content downloaded from 128.59.161.75 on Tue, 20 Oct 2015 17:19:58 UTC
All use subject to JSTOR Terms and Conditions
834 INFECTION CONTROL AND HOSPITrAL EPIDEMIOLOGY November 1998 
PPD-positive at study entry, including those listed in Table 
2, plus a history of BCG vaccination. Of greater interest are 
the factors not associated with baseline positivity, including 
working with HIV-infected populations in general, job cate- 
gory or description, amount and type of patient contact, and 
performing cough-inducing procedures such as sputum 
collection (although these procedures were done by only a 
small number of the HCWs in our study). Our baseline data 
reflect lifetime exposure, including cumulative time in 
health care, as well as exposure from the community. Some 
studies have found a correlation between TB infection and 
lower socioeconomic status that is stronger than the risk of 
infection through occupational exposure.21'22 It also may be 
that length of time as a HCW is a surrogate marker for age. 
These data are supported by the work of Bailey et al,22 who 
found that stratifying HCWs based on the amount of patient 
contact was not useful in determining the risk of previous- 
ly acquired TB infection. 
A study done at a New York City hospital identified 
the same independent predictors of a reactive tuberculin 
skin test among new employees hired between 1991 and 
1993.23 There was a baseline prevalence of 40% among 
these employees, which is higher than but comparable to 
our NYC rate of 31%. Another NYC hospital reported simi- 
lar findings, with a baseline prevalence of 45% in 1991.24 
During the 33-month follow-up period for this study, 
we noted a PPD conversion rate of 1.8 per 100 person 
years, with a total of 19 (2.5%) HCWs having skin tests 
being reported as newly reactive and 3 others (0.5%) who 
received TB prophylaxis and were counted as converters. 
Their inclusion may make the conversion rate slightly 
overestimated. Had they not been included, the rate would 
have been 1.6 per 100 person years. National rates of PPD 
conversion for HCWs in non-outbreak, non-HIV-specific 
settings is reported to be <2% per year,20,25 which is com- 
parable to our results. A Centers for Disease Control and 
Prevention (CDC) study of HCWs in Boston and NYC 
reported a conversion rate of 1.4% for participants who had 
received at least one follow-up skin test, scheduled every 6 
months.26 "High-risk" HCWs from the 1993 SHEA-CDC 
TB Survey had an average annual conversion rate of 1.2%, 
with a maximum rate of 2.8% at hospitals with less strin- 
gent TB control measures.27 
Rates of skin-test conversion have been reported 
from individual hospitals. At a Canadian hospital, Liss and 
colleagues found a somewhat lower overall conversion rate 
of 0.86 per 100 person years.28 However, those HCWs with 
greater exposure to patients with active TB had a higher 
proportion of PPD conversions, up to 5% over the 42-month 
study period for emergency room staff. Another study from 
a hospital in NYC documented a 3.1% overall skin-test con- 
version rate during an 18-month pre-intervention period 
from January 1990 to June 1991, with higher rates for those 
with more direct patient contact (6.4% vs 1.0%).29 However, 
after instituting additional transmission control measures 
for the intervention period of July 1991 to August 1992, con- 
version rates for these two general groups were similar 
(4.7% vs 2.3%), while the overall conversion rate remained 
the same at 3.0%. There also were no significant differences 
between those assigned to areas with higher proportions of 
patients with TB or HIV and those assigned to other areas. 
Our results suggest that working with HIV-infected 
populations, providing direct medical or nursing care, or 
working in the NYC area does not increase an individual's 
risk of acquiring TB infection. Our conversion rates for dif- 
ferent occupational categories (direct patient-care jobs vs 
other patient contact) were 1.7 and 1.8 per 100 person years 
respectively, significantly less than the average rate of 3.3 
in 1993 to 1994 reported by a NYC hospital with a high TB 
case rate.24 Our data show a trend toward higher conver- 
sion rates for HCWs who cared for a greater proportion of 
patients known to have active TB or who performed cough- 
inducing procedures and therefore were more likely to be 
exposed to aerosolized infectious particles. The apparently 
higher risk for those working in private practice may reflect 
less stringent infection control measures and a lower index 
of suspicion for TB. Many drug treatment programs and 
methadone clinics do not provide medical care on-site, pos- 
sibly contributing to a delay in the assessment of symptoms 
suggestive of TB. 
We attempted to evaluate the possible impact of the 
HIV status of the HCWs through the anonymous ques- 
tionnaires, which were included to assist in the interpreta- 
tion of PPD results. Castro and Dooley30 also note that HIV 
infection greatly increases an HCW's risk of developing 
active TB, if infected with Mycobacterium tuberculosis, 
thereby causing an apparent difference when evaluating 
relative risk. We noted the reluctance of some HCWs to 
provide HIV status information even in an anonymous for- 
mat (26%) and also that many providers working in HIV 
care did not know their own serostatus (28%). Few partici- 
pants (2%) reported being HIV-infected, however, so this 
information about HIV status and its effect on the inter- 
pretation of PPD results and conversion rates must be 
interpreted cautiously. Only 10 other participants reported 
a PPD induration of 5 to 10 mm that was classified as a non- 
conversion during the study follow-up period. Even if all 10 
were HIV-positive and should have been classified as PPD 
conversions, this would only increase our total conver- 
sions from 3% to 4%, with an event rate of 2.6 per 100 per- 
son years of follow-up. 
One limitation of this study was the difficulty in iden- 
tifying a valid external control group to determine the differ- 
ence in risk between HCWs caring for HIV-infected patients 
and HCWs caring for the general population. We were not 
able to collect data on the PPD status of other HCWs 
involved in non-HIV care within each participating unit For 
this reason, comparisons were made between different geo- 
graphical areas, amount and type of patient contact, degree 
of potential exposure to TB, and other demographic factors. 
Within our cohort, we found no significant relation between 
the proportion of patients cared for who were HIV-positive 
and subsequent PPD conversion. Because the number of 
conversions was small, however, such a relation may have 
been missed. Another limitation was that each unit request- 
ed the autonomy to assess TB risk for their HCWs and to 
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make medical decisions about conversion and the need for 
prophylaxis. This may have led to the inclusion of up to five 
HCWs who were not true converters, but it does indicate 
community practice in TB risk assessment. 
Our data provide some reassurance that caring for 
HIV-infected patients in itself is not an independent source of 
increased risk of TB infection in HCWs. A high index of sus- 
picion for TB when evaluating all patients, rigorous compli- 
ance with infection control guidelines, and careful follow-up 
to ensure compliance with treatment regimens should mini- 
mize the potential for infection with TB.31,32 An awareness 
among HCWs that the incidence of TB among HIV-infected 
clients is high relative to noninfected clients, balanced 
against our data showing no independent increased preva- 
lence or incidence ofTB infection in those who work direct- 
ly with HIV-infected patients, should assist HCWs in protect- 
ing themselves without undue fear of the HIV-infected 
patient. The greater risk for acquiring TB infection appears 
to be related to the prevalence of the disease in the commu- 
nity and in the overall patient population, and not specifically 
to occupational exposure to HIV-infected patients.22 
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